• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John H. Bauer, MD

Arch Intern Med. 1983;143(6):1163-1167.

Abstract

• Guanabenz acetate is a new centrally acting ₂-adrenergic agonist. Seventeen hypertensive men, in whom BP was normalized with guanabenz, underwent assessment of renal function, renal hemodynamics, and body fluid composition following short-term (three to six weeks), long-term (five to six months), and withdrawal (two weeks) therapy. Guanabenz therapy caused a modest but reversible reduction in glomerular filtration rate (12% to 18%), effective renal plasma flow (9% to 17%), and renal blood flow (12% to 20%). Renal vascular resistance was unchanged. Guanabenz therapy had no significant natriuretic or antinatriuretic effects in patients with an effective BP decrease, although it had the ability to produce and sustain a water diuresis. Guanabenz therapy was not associated with salt and water increases within body fluid compartments. Guanabenz, in some patients, is an effective monotherapy for the treatment of hypertension.

(Arch Intern Med 1983;143:1163-1167)

Author Affiliations

Footnotes

Reprint requests to Medical Service (111), The Harry S Truman Memorial Veterans Hospital, Columbia, MO 65201 (Dr Bauer).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
Maki et al.
Arch Intern Med 1995;155:1073-1080.
ABSTRACT  

Effects of Indoramin Therapy on BP, Renal Function, and Body Fluid Composition
Bauer et al.
Arch Intern Med 1984;144:308-312.
ABSTRACT